Barely Significant
← all phrases

“nominally significant”

7,733 sentences · 7,733 papers · 10,034 search hits before verification · confirmed specimen

Sighted at

p=0.08

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

nominally significantP < 0.0010.0× alphagold
Wake after sleep onset (WASO) declined significantly in response to the 400-mg dose relative to placebo (mean treatment effect –54 min; P < 0.001), and dose-related, clinically relevant, and nominally significant improvements were observed after almorexant doses of 200 ( P < 0.001) and 100 mg ( P = 0.004) ( Figure 1c ).
nominally significantp ≤ 1 × 10 −30.0× alphagold
SNV/INDEL association analysis Fisher’s exact test identified 4594 (5743), 5019 (6063), and 5066 (5959) autosomal (total numbers in parentheses) nominally significant ( p ≤ 1 × 10 −3 ) genetic variants (SNVs/INDELs) for neutropenia, leukopenia, and thrombocytopenia, respectively.
nominally significantP = 0.0010.0× alphagold
Of the nominally significant proteins (Figure S9 in supporting information), several cytokines and immune‐related proteins (interleukin [IL]‐6, logFC = –0.668, P = 0.001; tumor necrosis factor [TNF], logFC = –0.299, P = 0.017; C‐reactive protein [CRP], logFC = –0.45, P = 0.018; IL‐15, logFC = –0.23, P = 0.027; IL‐9, logFC = 0.54, P = 0.49), amyloid peptides (Aβ38, logFC = –0.45, P = 0.004; Aβ42, logFC = –0.43, P = 0.011) and proteins implicated in synucleinopathies (PARK7, logFC = –0.912, P = 0.027; FABP3, logFC = –0.370, P = 0.036) were downregulated.
nominally significantP <.0010.0× alphagold
Among the 49 patients in the intervention group and 51 in the control group undergoing postoperative chemotherapy, a nominally significant improvement in the change from baseline in the EORTC-QLQ-C30 total score at 3 months was observed compared to the control group (difference of 4.42; P <.001).
nominally significantP = 1E−030.0× alphagold
In relation to why previous GWA studies have not previously identified ABCC5 as a T2D susceptibility gene, it is worth noting that while individual nominally significant SNP p-values nearest to the estimated ABCC5 variant location at 185,136 kb for the WTCCC (e.g. rs3749441, P = 1E−03), NIDDK (e.g. rs1016752, P = 0.04) and TwinsUK samples (e.g. rs8180093, P = 0.002) do not pass genome-wide significance ( α = 1E−05), when all the SNPs in the region are considered collectively as part of a multilocus model, they do provide strong evidence of association with T2D and insulin resistance (meta-analysis P = 3E−07).
nominally significantP < 0.0010.0× alphagold
Gene ontology (GO) enrichment analysis identified 128 nominally significant enriched terms (see Table S3 for genes included in the analysis) for the DMPs ( P < 0.001) identified in the age 10 analysis, including several related to the etiology of psychosis, such as glutamatergic synaptic transmission (GO:0051966, P = 0.0034) and neuron projection development (GO:0031175, P = 0.0064).
nominally significantp = 0.0010.0× alphagold
3.2.1 COPD We identified a nominally statistical association between CHRNA3 rs1051730 and COPD risk under the allelic and dominant models in all populations (allelic model: OR = 1.630, 95% CI = 1.293–2.054, p < 0.001; dominant model: OR = 1.662, 95% CI = 1.300–2.124, p < 0.001), a nominally significant association under the allelic and dominant models in Asians (allelic model: OR = 1.591, 95% CI = 1.204–2.103, p = 0.001; dominant model: OR = 1.625, 95% CI = 1.222–2.160, p = 0.001), and a null association under all three models in Caucasians.